Daniel P. Mundt

Daniel Mundt practices at Minnesota Oncology Hematology PA in Maple Grove, Minnesota.

Daniel Mundt's NPI, 1053870147, was assigned on March 18, 2019. Daniel Mundt holds Wisconsin license 75101.

Daniel Mundt's primary practice is Minnesota Oncology Hematology PA, at 10150 Niagara N Ln, Maple Grove, MN 55369 in Hennepin County. The practice phone is (844) 317-4673.

Daniel Mundt's primary practice is Minnesota Oncology Hematology PA in Maple Grove, Minnesota. Daniel Mundt is also affiliated with Aurora St. Luke's Medical Center. The medical group on file is Minnesota Oncology. Dmand AI also links Daniel Mundt to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Daniel Mundt practices, 3 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Daniel Mundt's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Daniel Mundt is licensed in Wisconsin.

CMS data shows 25 Medicare services from Daniel Mundt across 1 procedure code in 2024, for 44 Medicare patients. Medicare paid $2,200 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 44 Medicare patients who saw Daniel Mundt in 2024. The largest group is 75 to 84, with 16 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 34% are also on Medicaid. Their average risk score is 3.00, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Daniel Mundt's median patient age at 67, with 61% women.

In 2024, Daniel Mundt wrote 361 Medicare Part D claims for 73 patients. 84% of them were for generic drugs. CMS names the drug for 205 of them, across 6 drugs with 11 or more claims each, at $38,530 in total drug cost. In 2023, CMS named 99 claims across 5 drugs.

Daniel Mundt accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 6 papers to Daniel Mundt, published from 2019 to 2022. 2022 was the busiest year, with 2. The most frequent topics are COVID-19, COVID-19 Testing and SARS-CoV-2. Daniel Mundt's most frequent co-authors are Babar Bashir, MD, Stephanie Ann Berg, DO and Mehmet Asim Bilen, MD.

CMS Open Payments shows 1 general payment to Daniel Mundt from 1 drug or device company in 2024. Food and beverage make up the largest share, 100% of the total. Janssen Pharmaceuticals, Inc paid the most, $35.